{
  "actions": [
    {
      "acted_at": "2021-02-18",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2021-02-18",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2021-02-19",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr1186-117",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "B001307",
      "district": "4",
      "name": "Baird, James R.",
      "original_cosponsor": true,
      "sponsored_at": "2021-02-18",
      "state": "IN",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001190",
      "district": "2",
      "name": "Mullin, Markwayne",
      "original_cosponsor": false,
      "sponsored_at": "2021-10-25",
      "state": "OK",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-02-18",
  "number": "1186",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat of counterfeit drugs to the pharmaceutical supply chain, and to make the pharmaceutical supply chain more robust, while ensuring the authenticity, content, purity, and manufacturing location and batch number of drugs (including COVID-19 therapeutics and vaccines) and allowing patient verification of authenticity, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Supply Chain Security and Pharmaceutical Authentication Act of 2021",
  "sponsor": {
    "bioguide_id": "V000133",
    "district": "2",
    "name": "Van Drew, Jefferson",
    "state": "NJ",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-02-18",
  "subjects": [
    "Drug safety, medical device, and laboratory regulation",
    "Health",
    "Manufacturing"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2021-02-18",
    "date": "2021-04-01T21:14:10Z",
    "text": "Supply Chain Security and Pharmaceutical Authentication Act of 2021 \n\nThis bill modifies the application of requirements for drug packaging to include certain information, such as the product's lot number and expiration date.\n\nUnder the bill, the requirements shall apply to the packaging of the smallest or individual solid oral dosage form of the product. Currently, such requirements apply to the smallest container (which might contain multiple dosages) of the product that is intended for individual sale to a dispenser, such as a pharmacy."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Supply Chain Security and Pharmaceutical Authentication Act of 2021",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat of counterfeit drugs to the pharmaceutical supply chain, and to make the pharmaceutical supply chain more robust, while ensuring the authenticity, content, purity, and manufacturing location and batch number of drugs (including COVID-19 therapeutics and vaccines) and allowing patient verification of authenticity, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Supply Chain Security and Pharmaceutical Authentication Act of 2021",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:47:19Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr/BILLSTATUS-117hr1186.xml"
}